Tuesday, April 28, 2026

YG Plus Shares Drop 11% After Rosé’s “APT.” Success Boosted Stock

YG Plus stock dropped 11% on Tuesday, following a surge from Rosé's "APT." Poor earnings and profit-taking contributed to the decline.

New Obesity Drug Shows Big Promise — and It’s Not from Eli Lilly or Novo

Metsera leads emerging obesity treatments with promising drug MET-233i, showing significant weight loss in trials, amid rising competition.

How Daewoong, Naver, and J&P Medi are Transforming Digital Health: Key Insights from the 2026 Partners Day

The event showcases 10 startups presenting innovations in digital healthcare, focusing on AI, brain health, and business strategies.

Tag: KC-135

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.